Here, we extend these findings to molecular biomarkers, demonstrating that rs34173062′s minor allele associates with increased CSF amyloid levels and a trend toward higher Braak neurofibrillary tangle stage, linking SHARPIN variation not only to structure but also to hallmark AD pathology. The gene discussed is SHARPIN; the disease is Alzheimer disease.